- Graduate School - University of North Carolina at Greensboro (1978-1983), Psychology
- Internship - University of Mississippi and VA Center Consortium (1983-1984), Clinical Psychology
- Internship - Beck Institute for Cognitive Therapy and Research (2000-2001), Cognitive Therapy
Robin Jarrett, Ph.D.
- Elizabeth H. Penn Professorship in Clinical Psychology
Dr. Jarrett is a licensed psychologist who is board certified in clinical psychology. Her research and clinical expertise is in promoting health and wellness, particularly for patients with mood and related disorders. She specializes in short-term, evidenced-based psychotherapy and focuses on cognitive behavioral therapy. In the Department of Psychiatry at UT Southwestern, Dr. Jarrett collaborates on research, treats patients, teaches, and supervises clinical and/or research activities of trainees. Since 1989 Dr. Jarrett has directed the Psychosocial Research and Depression Clinic where the National Institute of Mental Health (NIMH) has funded her research group across decades. She welcomes collaborators and trainees dedicated to understanding the role of psychosocial factors in the course of health and illness, particularly in mood and related disorders.
A partial listing of Dr. Jarrett’s publications can be found below and a more complete listing is available to interested readers at: http://www.ncbi.nlm.nih.gov/myncbi/robin.jarrett.1/bibliography/41161566/public/?sort=date&direction=ascending.
- American Board of Professional Psychology (ABPP) (2017), Board Certified Clinical Psychologist
- American Psychological Association (APA) Society of Clinical Psychology Mentorship Program (2017-2018)
- Association for Psychological Science (APS) (2010-2018)
- Editorial Board: Journal of Consulting and Clinical Psychology (2004-2016)
- Association for Behavioral and Cognitive Therapy (ABCT) (1978-2018)
- American Psychological Association (APA) (1984-2018)
- International Association for Cognitive Psychotherapy (1989-2018)
- Texas Psychological Association (TPA) (1990-2018)
- Reviewers Reserve [NIMH] (1990-2018)
- Dallas Psychological Association (DPA) (1993-2018)
- Fellow 2006, Hedwig van Ameringen Executive Leadership in Academic Medicine (ELAM)
- Certified Consultant and Trainer 2013-2018, Academy of Cognitive Therapy
- Principal Investigator with career awards, Funded by the National Institute of Mental Health
- Diplomate and Founding Fellow 1999-2018, Academy of Cognitive Therapy
- Fourjay Scholar 2000, The Fourjay Foundation, The Beck Institute, Extramural Training Program
- Elizabeth H. Penn Professorship in Clinical Psychology 2004-2018, The University of Texas Southwestern Medical Center
Reducing relapse in depressed outpatients with atypical features: a pilot study.
Jarrett RB, Kraft D, Schaffer M, Witt-Browder A, Risser R, Atkins DH, Doyle J Psychotherapy and psychosomatics 2000 Sep-Oct 69 5 232-9
Is there a role for continuation phase cognitive therapy for depressed outpatients?
Jarrett RB, Basco MR, Risser R, Ramanan J, Marwill M, Kraft D, Rush AJ Journal of consulting and clinical psychology 1998 Dec 66 6 1036-40
Treatment of atypical depression with cognitive therapy or phenelzine: a double-blind, placebo-controlled trial.
Jarrett RB, Schaffer M, McIntire D, Witt-Browder A, Kraft D, Risser RC Archives of general psychiatry 1999 May 56 5 431-7
Comparative efficacy and durability of continuation phase cognitive therapy for preventing recurrent depression: design of a double-blinded, fluoxetine- and pill placebo-controlled, randomized trial with 2-year follow-up.
Jarrett RB, Thase ME Contemporary clinical trials 2010 Jul 31 4 355-77
Multiple measures, methods, and moments: a factor-analytic investigation of change in depressive symptoms during acute-phase cognitive therapy for depression.
Vittengl JR, Clark LA, Kraft D, Jarrett RB Psychological medicine 2005 May 35 5 693-704
Prophylactic Cognitive Therapy for Major Depressive Disorder.
Jarrett, R. B., & Kraft, D. In Session:Psychotherapy in Practice 1997 3 3 65-79
Cognitive-behavioral therapy to prevent relapse in pediatric responders to pharmacotherapy for major depressive disorder.
Kennard BD, Emslie GJ, Mayes TL, Nightingale-Teresi J, Nakonezny PA, Hughes JL, Jones JM, Tao R, Stewart SM, Jarrett RB Journal of the American Academy of Child and Adolescent Psychiatry 2008 Dec 47 12 1395-404
Patients' comprehension and skill usage as a putative mediator of change or an engaged target in cognitive therapy: Preliminary findings.
Jarrett RB, Vittengl JR, Clark LA, Thase ME Journal of affective disorders 2017 Sep 226 163-168
Divergent Outcomes in Cognitive-Behavioral Therapy and Pharmacotherapy for Adult Depression.
Vittengl JR, Jarrett RB, Weitz E, Hollon SD, Twisk J, Cristea I, David D, DeRubeis RJ, Dimidjian S, Dunlop BW, Faramarzi M, Hegerl U, Kennedy SH, Kheirkhah F, Mergl R, Miranda J, Mohr DC, Rush AJ, Segal ZV, Siddique J, Simons AD, Cuijpers P The American journal of psychiatry 2016 Feb appiajp201515040492
Defined symptom-change trajectories during acute-phase cognitive therapy for depression predict better longitudinal outcomes.
Vittengl JR, Clark LA, Thase ME, Jarrett RB Behaviour research and therapy 2016 Aug 87 48-57
Developing Cognitive Behavioral Therapy to Prevent Depressive Relapse in Youth.
Kennard BD, Stewart SM, Hughes JL, Jarrett RB, Emslie GJ Cognitive and behavioral practice 2008 Nov 15 4 387-399
The Role of Dyadic Discord in Outcomes in Acute Phase Cognitive Therapy for Adults With Recurrent Major Depressive Disorder.
Trombello JM, Vittengl JR, Denton WH, Minhajuddin A, Thase ME, Jarrett RB, Behavior therapy 2019 Jul 50 4 778-790
Partner criticism during acute-phase cognitive therapy for recurrent major depressive disorder.
Vittengl JR, Clark LA, Thase ME, Jarrett RB Behaviour research and therapy 2019 Feb 113 48-56
Initial Steps to inform selection of continuation cognitive therapy or fluoxetine for higher risk responders to cognitive therapy for recurrent major depressive disorder.
Vittengl JR, Anna Clark L, Thase ME, Jarrett RB Psychiatry research 2017 Mar 253 174-181
Assessing Cognitive Therapy Skills Comprehension, Acquisition, and Use by Means of an Independent Observer Version of the Skills of Cognitive Therapy (SoCT-IO).
Brown GK, Thase ME, Vittengl JR, Borman PD, Clark LA, Jarrett RB Psychological assessment 2015 Sep
Predictors of longitudinal outcomes after unstable response to acute-phase cognitive therapy for major depressive disorder.
Vittengl JR, Clark LA, Thase ME, Jarrett RB Psychotherapy (Chicago, Ill.) 2015 Jun 52 2 268-77
Quantifying and Qualifying the Preventive Effects of Acute-Phase Cognitive Therapy: Pathways to Personalizing Care.
Jarrett RB, Minhajuddin A, Vittengl JR, Clark LA, Thase ME Journal of consulting and clinical psychology 2015 Dec
Preventing Depressive Relapse and Recurrence in Higher-Risk Cognitive Therapy Responders: A Randomized Trial of Continuation Phase Cognitive Therapy, Fluoxetine, or Matched Pill Placebo.
Jarrett RB, Minhajuddin A, Gershenfeld H, Friedman ES, Thase ME JAMA psychiatry (Chicago, Ill.) 2013 Sep
Acute phase cognitive therapy for recurrent major depressive disorder: Who drops out and how much do patient skills influence response?
Jarrett RB, Minhajuddin A, Kangas JL, Friedman ES, Callan JA, Thase ME Behaviour research and therapy 2013 Jan 51 4-5 221-230
Skills of Cognitive Therapy (SoCT): A new measure of patients' comprehension and use.
Jarrett RB, Vittengl JR, Clark LA, Thase ME Psychological assessment 2011 Feb 578-86
Changes in cognitive content during and following cognitive therapy for recurrent depression: substantial and enduring, but not predictive of change in depressive symptoms.
Jarrett RB, Vittengl JR, Doyle K, Clark LA Journal of consulting and clinical psychology 2007 Jun 75 3 432-46
Preventing recurrent depression using cognitive therapy with and without a continuation phase: a randomized clinical trial.
Jarrett RB, Kraft D, Doyle J, Foster BM, Eaves GG, Silver PC Archives of general psychiatry 2001 Apr 58 4 381-8
Could Treatment Matching Patients' Beliefs About Depression Improve Outcomes?
Vittengl JR, Clark LA, Thase ME, Jarrett RB, Behavior therapy 2019 Jul 50 4 765-777
Do comorbid social and other anxiety disorders predict outcomes during and after cognitive therapy for depression?
Vittengl JR, Clark LA, Smits JAJ, Thase ME, Jarrett RB Journal of affective disorders 2019 Jan 242 150-158
Relations of Shared and Unique Components of Personality and Psychosocial Functioning to Depressive Symptoms.
Vittengl JR, Clark LA, Thase ME, Jarrett RB Journal of personality disorders 2017 Sep 1-26
- Reducing relapse in depressed outpatients with atypical features: a pilot study.
- Psychosocial factors and interventions that promote health
- Mood and related disorders
- Evidence-based psychotherapy
- Cognitive-behavioral therapy